PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
NCT01156857
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
209
Enrollment
INDUSTRY
Sponsor class
Conditions
Uterine Fibroids
Interventions
DRUG:
PGL4001, placebo
DRUG:
PGL4001, progestin
Sponsor
PregLem SA